Efficacyand Safety of Palbociclib (PAL) PUS Fulvestrant (F) by Geographic Region in Women with Endocrine-Resistant Hormone Receptor-Positive (HR+), Human Epiderman Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) from Paloma-3
Titel:
Efficacyand Safety of Palbociclib (PAL) PUS Fulvestrant (F) by Geographic Region in Women with Endocrine-Resistant Hormone Receptor-Positive (HR+), Human Epiderman Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) from Paloma-3
Auteur:
Harbeck, Nadia Colleoni, Marco Demichele, Angela Turner, Nicholas C. Cristofanilli, Massimo Verma, Shailendra Sleckman, Bethany Huang, Xin Theall, Kathy Puyana Bananis, Eustratios Masuda, Norikazu Im, Seock-Ah